Showing results (1351-1360 of 1,422) with videos related to
Sort By:
Pageof 143
Medicine|May 5, 2017
Increased risk of ventricular tachycardia and cardiovascular death in patients with myocarditis during the long-term follow-up: A national representative cohort from the National Health Insurance Research DatabaseAbigail Louise D Te, Tao-Cheng Wu, Yenn-Jiang Lin, et al.Leukemia|February 26, 2020
Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironmentChengxiang Xia, Tongjie Wang, Hui Cheng, et al.The Journal of Clinical Investigation|June 20, 2023
Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host diseaseYan Lin, Quan Gu, Shihong Lu, et al.Blood|April 21, 2021
Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damageLinping Hu, Xiuxiu Yin, Yawen Zhang, et al.Blood|May 8, 2026
Procr+ endothelial progenitor cells govern hematopoiesis through fine-tuning mesenchymal stem cell niche signalsChang Xu, Xue Lv, Shangda Yang, et al.Blood Advances|September 3, 2021
Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18INK4CYinghui Li, Wenshan Zhang, Yu Zhang, et al.Lung Cancer (Amsterdam, Netherlands)|October 30, 2020
Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective studyJiang-Tao Cheng, Yi-Hui Yao, Yu-Er Gao, et al.Cell Stem Cell|February 23, 2021
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative NeoplasmsJingyuan Tong, Ting Sun, Shihui Ma, et al.Nature Communications|February 19, 2015
Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cellsYingdai Gao, Peng Yang, Hongmei Shen, et al.Blood Advances|October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agentsYuting Yan, Xuehan Mao, Jiahui Liu, et al.Pageof 143